![](/img/cover-not-exists.png)
Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging
Tawakol, Ahmed, Singh, Parmanand, Rudd, James H.F., Soffer, Joseph, Cai, Gengqian, Vucic, Esad, Brannan, Sarah P., Tarka, Elizabeth A., Shaddinger, Bonnie C., Sarov-Blat, Lea, Matthews, Paul, SubramanVolume:
63
Language:
english
Journal:
Journal of the American College of Cardiology
DOI:
10.1016/j.jacc.2013.07.050
Date:
January, 2014
File:
PDF, 426 KB
english, 2014